BioVaxys and BioElpida Sign Term Sheet for Clinical Grade BVX-0918A Bio-production
Canada NewsWire SIGNIFICANT ADVANCEMENT TOWARDS LAUNCH OF PHASE I OVARIAN CANCER VACCINE TRIALVANCOUVER, BC,Feb. 18, 2021/CNW/ — BioVaxys Technology
Read moreCanada NewsWire SIGNIFICANT ADVANCEMENT TOWARDS LAUNCH OF PHASE I OVARIAN CANCER VACCINE TRIALVANCOUVER, BC,Feb. 18, 2021/CNW/ — BioVaxys Technology
Read moreInternationally Recognized Art Expert Jean-David Malat Joins FACT Advisory Board Renowned Curator Brings his Art of Relationships to Expand FACT”s
Read moreMibelle Biochemistry’s Ability to Introduce Breakthrough Active Ingredients for the Personal Care Market Lauded by Frost & Sullivan Canada
Read more